Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The Medicines Co., in pivot to pipeline PCSK9 med, secures $270M asset sale
The Medicines Co., in pivot to pipeline PCSK9 med, secures $270M asset sale
The Medicines Co., in pivot to pipeline PCSK9 med, secures $270M asset sale
Submitted by
admin
on November 29, 2017 - 10:15am
Source:
Fierce Pharma
News Tags:
The Medicines Company
PCSK9 inhibitors
inclisiran
Vabomere
Headline:
The Medicines Co., in pivot to pipeline PCSK9 med, secures $270M asset sale
Do Not Allow Advertisers to Use My Personal information
